This study tested introducing the Standard Days Method/CycleBeads in Title X family planning clinics. Preliminary findings show that clients chose CycleBeads to avoid hormones and found it easy to use. Staff were trained and systems were modified to integrate CycleBeads. Over 200 clients used CycleBeads in the first year and follow up interviews found high satisfaction and correct use rates. The study aims to develop a replicable process for introducing new fertility awareness methods in clinics to expand contraceptive choice.
SM2015 is an ambitious project with the Ministry of Health and local support. This presentation outlines the design and activities around the data collection and analysis of the evaluation, as well as the results, conclusions, and future activities.
1) The document summarizes preliminary findings from a process evaluation of the Salud Mesoamerica Initiative (SMI) which aims to strengthen health systems in Mesoamerica.
2) Key findings include that SMI has improved health facility management, logistics and medical supply availability, information systems, and human resource training.
3) SMI also influenced policies by changing conversations to focus on results and accelerating policy approval processes in Chiapas, Mexico. However, stakeholders disagreed on whether SMI adequately prioritized the poor.
AAA Screening : Extending the screener role for nursesPHEScreening
The document discusses extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. The program saw a decline in eligible men for screening over time as the population grew. The extended screener role would have technicians take basic observations like blood pressure and seek nurse practitioner advice if needed. Patients would receive education materials and follow up calls. Nurses would conduct further assessments over the phone. The changes aim to catch other health issues and assure quality through training, audits, and patient and doctor feedback. The feedback received has been positive.
AAA Screening : Extending the screener rolePHEScreening
This document describes extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. It provides details on the current and proposed screening models, including the additional training and guidance technicians receive to take blood pressure and seek nurse advice. An example is given of how a high blood pressure reading was identified during screening and subsequently treated, benefiting both the patient and their GP. Feedback from patients and GPs is positive about the expanded technician role in detecting other health issues alongside AAA screening.
This study tested introducing the Standard Days Method/CycleBeads in Title X family planning clinics. Preliminary findings show that clients chose CycleBeads to avoid hormones and found it easy to use. Staff were trained and systems were modified to integrate CycleBeads. Over 200 clients used CycleBeads in the first year and follow up interviews found high satisfaction and correct use rates. The study aims to develop a replicable process for introducing new fertility awareness methods in clinics to expand contraceptive choice.
SM2015 is an ambitious project with the Ministry of Health and local support. This presentation outlines the design and activities around the data collection and analysis of the evaluation, as well as the results, conclusions, and future activities.
1) The document summarizes preliminary findings from a process evaluation of the Salud Mesoamerica Initiative (SMI) which aims to strengthen health systems in Mesoamerica.
2) Key findings include that SMI has improved health facility management, logistics and medical supply availability, information systems, and human resource training.
3) SMI also influenced policies by changing conversations to focus on results and accelerating policy approval processes in Chiapas, Mexico. However, stakeholders disagreed on whether SMI adequately prioritized the poor.
AAA Screening : Extending the screener role for nursesPHEScreening
The document discusses extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. The program saw a decline in eligible men for screening over time as the population grew. The extended screener role would have technicians take basic observations like blood pressure and seek nurse practitioner advice if needed. Patients would receive education materials and follow up calls. Nurses would conduct further assessments over the phone. The changes aim to catch other health issues and assure quality through training, audits, and patient and doctor feedback. The feedback received has been positive.
AAA Screening : Extending the screener rolePHEScreening
This document describes extending the role of screening technicians in an abdominal aortic aneurysm (AAA) screening program to include basic physical health checks. It provides details on the current and proposed screening models, including the additional training and guidance technicians receive to take blood pressure and seek nurse advice. An example is given of how a high blood pressure reading was identified during screening and subsequently treated, benefiting both the patient and their GP. Feedback from patients and GPs is positive about the expanded technician role in detecting other health issues alongside AAA screening.
The document summarizes a study on the effectiveness of a quality improvement collaborative (QIC) approach to accelerate the elimination of mother-to-child transmission of HIV (eMTCT) in South Africa. Key findings include:
1) The QIC approach achieved rapid improvements in eMTCT program outcomes such as increased early antenatal booking rates, HIV retesting rates, and postnatal visit rates.
2) Improvements were seen across different types and sizes of health facilities in the Eastern Cape province.
3) The success of the QIC approach was influenced by facilities' baseline performance, quality improvement skills training, leadership support, and organizational commitment to quality improvement.
This document describes the Pediatrix Clinical DataWarehouse and its role in quality improvement initiatives for neonatal medicine. The Clinical DataWarehouse contains clinical data on over 700,000 patients and is one of the largest databases for neonatal outcomes. Data from electronic medical records is extracted and analyzed to identify areas for improvement. Quality improvement projects are developed and tracked using the QualitySteps system. Analyzing outcomes data allows Pediatrix to benchmark performance and drive continuous quality improvement that improves patient care.
The document summarizes evidence from a systematic review and randomized controlled trial on the use of antenatal corticosteroids in low-resource settings. The systematic review found that antenatal corticosteroids reduced rates of RDS, neonatal death, intraventricular hemorrhage, necrotizing enterocolitis, and early-onset sepsis in preterm infants without increasing maternal infections. A large multicountry randomized trial demonstrated that dexamethasone reduced neonatal mortality and respiratory morbidity without affecting maternal outcomes. While the trial had some limitations, it provided strong evidence that antenatal corticosteroids can safely reduce preterm birth complications in resource-limited settings.
This document describes an obstetric enhanced recovery program aimed at reducing hospital stay after cesarean sections without increasing complications. The program provides evidence-based care including early mobilization, catheter removal within 6 hours, and discharge within 24-36 hours. An audit of 30 cases found some improvements in identifying eligible women but also areas for further improvement such as completing discharge prescriptions in the operating theater and documenting reasons for delays in the enhanced recovery pathway. Recommendations include improving these areas as well as staff engagement to fully implement the program.
This powerpoint presentation was put together by Dr. Janice Carson, Assistant Chief for Performance Quality and Outcomes, Medical Assistance Plans, Dept. of Community Health, and presented on August 26 as part of our GA-CAN! Community Conversation on Medicaid and Peachcare.
The document provides an agenda and details for a regional event on the Newborn and Infant Physical Examination (NIPE) Screening Programme. The event will include updates on the NIPE programme and NIPE SMART system, as well as sessions on using NIPE SMART and quality assurance.
NIPE national programme update Jill WalkerPHEScreening
The document provides an agenda and details for a regional event on the Newborn and Infant Physical Examination (NIPE) Screening Programme. The event will include updates on the NIPE programme and NIPE SMART system, as well as sessions on quality assurance and using the NIPE SMART user guide.
Clinical audit for the enlightened ian callanan hslg conference 2013hslgcommittee
This document provides an overview of clinical audit, including:
- Clinical audit aims to systematically review and improve patient care by comparing current practices to standards and research.
- It identifies areas for waste reduction, good practice promotion, and stopping bad practices while improving professional practice, outcomes, and releasing funds for better patient care.
- Successful clinical audits follow a plan-do-check-act cycle, have clear standards and criteria, measure current performance, validate findings, and make appropriate changes to close the loop through re-evaluation.
Implementing Physician Assistants in the ED to improve patient experience Criterion Conferences
• Supporting doctors to help expedite patient care
• Ensuring high quality and timely care
• Examining effectiveness one year on
Benjamin Close Director Emergency Townsville Hospital, QLD
The document summarizes the results of a baseline study conducted as part of the Salud Mesoamérica Initiative, which aims to improve health indicators in Central American and Mexican countries. Key findings from household and health facility surveys in multiple countries are presented. Dried blood spot samples were also collected and tested to estimate measles immunization coverage, identifying gaps between reported vaccination and presence of antibodies. Health facility characteristics associated with discrepancies included lack of internet access and inconsistent receipt of requested vaccine supplies. The study highlights opportunities to strengthen vaccination programs and better measure coverage through biomarkers.
1. The study tested a quality improvement intervention using learning teams for reflective adaptation (RAP) to enhance diabetes and hypertension care in primary care practices.
2. The intervention was tested on 56 practices randomized to an intervention or control group. Patient medical records were reviewed at baseline and 2 years.
3. Preliminary results found modest improvements in some quality measures for diabetes and hypertension care in the intervention practices compared to controls. Further qualitative analysis of the RAP process may provide insights into how practices implemented changes.
Supporting Population Health Management by Andrew Bloschichak, MD, MBA Benjamin Pease
This document discusses population health management and value-based payment models. It provides an overview of Highmark's approach, which includes pay-for-performance and accountable care organization programs. Quality and cost/utilization are measured across multiple metrics and used to determine provider payments. The goal is to shift from fee-for-service to value-based models to improve outcomes and lower costs.
AAA 2016 networking day final presentationsMike Harris
The document summarizes the results and updates from the NHS AAA Screening Programme. Some key points:
- Almost 1.3 million men were invited for screening, with an uptake of 79.5%
- Nearly 13,000 abdominal aortic aneurysms (AAA) larger than 3cm were detected, with a prevalence of 1.3%
- Options to extend surveillance intervals to biennially were presented, which could result in cost savings of over £600,000 per invited cohort.
- Evidence was presented on the risk of AAA progression in men with subaneurysmal aortas between 2.6-2.9cm, supporting potential rescreening of these men after 5 years.
This document discusses the importance of quality antenatal care. It outlines that antenatal care involves regularly monitoring the health of the mother and fetus during pregnancy. Quality antenatal care should include early registration within the first trimester, a minimum of four checkups with one by a medical officer, two tetanus injections, and 100 iron folic acid tablets. It also discusses estimating the expected number of pregnancies in an area and the importance of tracking all pregnant women.
The document discusses a study exploring the role of dietitians in multidisciplinary treatment of polycystic ovary syndrome (PCOS). The study involved a two-phase mixed methods design, beginning with an online survey of 261 healthcare providers, followed by focus groups with 9 providers. Survey results found that multidisciplinary clinics could improve access and outcomes for PCOS patients. Focus groups revealed that while dietitians play an important role in PCOS treatment, they face challenges like lack of referrals and insurance barriers. Providers felt more awareness and education are still needed on nutrition interventions for PCOS.
This document discusses a study exploring the role of dietitians in multidisciplinary treatment of polycystic ovary syndrome (PCOS). The study involved a two-phase mixed methods design, beginning with an online survey of 261 healthcare providers, followed by focus groups with 9 providers. Survey results found that multidisciplinary clinics could improve access and outcomes for PCOS patients. Barriers to multidisciplinary care included cost and differences of opinion. Focus groups revealed that while dietitians provide individualized nutrition counseling, their involvement is limited by lack of referrals and insurance coverage. Providers felt dietitians are underutilized for PCOS despite the importance of lifestyle interventions.
Elective care conference: imaging demand and capacity NHS Improvement
The document summarizes the results of demand and capacity modeling done for radiology services at Bradford Teaching Hospitals NHS Foundation Trust. The modeling found current deficits between 239-290 CT slots and 28-83 MRI slots per week to meet demand at the 65th-85th percentiles. For CT, there is also a backlog of 176-241 patients that requires clearing. The conclusions are that measuring demand, capacity, activity and backlog allows identification of bottlenecks and focus of improvement efforts, and justification of capital investments or alternate solutions to address shortfalls.
Este estudio evaluó la calidad de la información sobre mortalidad infantil en Yucatán, México entre 2015-2016. El análisis encontró que el sistema de registros vitales mostró buena calidad general pero con problemas en la certificación de causas de muerte, especialmente para neonatos. La concordancia entre registros médicos y estadísticas vitales varió según la causa. La Universidad de Yucatán diseñará intervenciones para mejorar la certificación de muertes infantiles.
The first phase of the “Under-5 Child Health and Mortality Statistics Project” sough to strengthen the evidence and understanding of key factors related to under-5 mortality in Yucatán, Mexico using Verbal Autopsy data collection tools with an added battery on search for care processes for U5 deaths which occurred in Yucatán during 2015-2016, and the triangulation of Verbal Autopsy reports with data from vital registration systems and medical records. This presentation, presented to stakeholders at a results dissemination workshop in October 2017 in Mérida, Yucatán, provides an overview of the project and summarizes key results and learnings from the research.
More Related Content
Similar to Salud Mesoamerica Initiative: Select results from the second operation measurement
The document summarizes a study on the effectiveness of a quality improvement collaborative (QIC) approach to accelerate the elimination of mother-to-child transmission of HIV (eMTCT) in South Africa. Key findings include:
1) The QIC approach achieved rapid improvements in eMTCT program outcomes such as increased early antenatal booking rates, HIV retesting rates, and postnatal visit rates.
2) Improvements were seen across different types and sizes of health facilities in the Eastern Cape province.
3) The success of the QIC approach was influenced by facilities' baseline performance, quality improvement skills training, leadership support, and organizational commitment to quality improvement.
This document describes the Pediatrix Clinical DataWarehouse and its role in quality improvement initiatives for neonatal medicine. The Clinical DataWarehouse contains clinical data on over 700,000 patients and is one of the largest databases for neonatal outcomes. Data from electronic medical records is extracted and analyzed to identify areas for improvement. Quality improvement projects are developed and tracked using the QualitySteps system. Analyzing outcomes data allows Pediatrix to benchmark performance and drive continuous quality improvement that improves patient care.
The document summarizes evidence from a systematic review and randomized controlled trial on the use of antenatal corticosteroids in low-resource settings. The systematic review found that antenatal corticosteroids reduced rates of RDS, neonatal death, intraventricular hemorrhage, necrotizing enterocolitis, and early-onset sepsis in preterm infants without increasing maternal infections. A large multicountry randomized trial demonstrated that dexamethasone reduced neonatal mortality and respiratory morbidity without affecting maternal outcomes. While the trial had some limitations, it provided strong evidence that antenatal corticosteroids can safely reduce preterm birth complications in resource-limited settings.
This document describes an obstetric enhanced recovery program aimed at reducing hospital stay after cesarean sections without increasing complications. The program provides evidence-based care including early mobilization, catheter removal within 6 hours, and discharge within 24-36 hours. An audit of 30 cases found some improvements in identifying eligible women but also areas for further improvement such as completing discharge prescriptions in the operating theater and documenting reasons for delays in the enhanced recovery pathway. Recommendations include improving these areas as well as staff engagement to fully implement the program.
This powerpoint presentation was put together by Dr. Janice Carson, Assistant Chief for Performance Quality and Outcomes, Medical Assistance Plans, Dept. of Community Health, and presented on August 26 as part of our GA-CAN! Community Conversation on Medicaid and Peachcare.
The document provides an agenda and details for a regional event on the Newborn and Infant Physical Examination (NIPE) Screening Programme. The event will include updates on the NIPE programme and NIPE SMART system, as well as sessions on using NIPE SMART and quality assurance.
NIPE national programme update Jill WalkerPHEScreening
The document provides an agenda and details for a regional event on the Newborn and Infant Physical Examination (NIPE) Screening Programme. The event will include updates on the NIPE programme and NIPE SMART system, as well as sessions on quality assurance and using the NIPE SMART user guide.
Clinical audit for the enlightened ian callanan hslg conference 2013hslgcommittee
This document provides an overview of clinical audit, including:
- Clinical audit aims to systematically review and improve patient care by comparing current practices to standards and research.
- It identifies areas for waste reduction, good practice promotion, and stopping bad practices while improving professional practice, outcomes, and releasing funds for better patient care.
- Successful clinical audits follow a plan-do-check-act cycle, have clear standards and criteria, measure current performance, validate findings, and make appropriate changes to close the loop through re-evaluation.
Implementing Physician Assistants in the ED to improve patient experience Criterion Conferences
• Supporting doctors to help expedite patient care
• Ensuring high quality and timely care
• Examining effectiveness one year on
Benjamin Close Director Emergency Townsville Hospital, QLD
The document summarizes the results of a baseline study conducted as part of the Salud Mesoamérica Initiative, which aims to improve health indicators in Central American and Mexican countries. Key findings from household and health facility surveys in multiple countries are presented. Dried blood spot samples were also collected and tested to estimate measles immunization coverage, identifying gaps between reported vaccination and presence of antibodies. Health facility characteristics associated with discrepancies included lack of internet access and inconsistent receipt of requested vaccine supplies. The study highlights opportunities to strengthen vaccination programs and better measure coverage through biomarkers.
1. The study tested a quality improvement intervention using learning teams for reflective adaptation (RAP) to enhance diabetes and hypertension care in primary care practices.
2. The intervention was tested on 56 practices randomized to an intervention or control group. Patient medical records were reviewed at baseline and 2 years.
3. Preliminary results found modest improvements in some quality measures for diabetes and hypertension care in the intervention practices compared to controls. Further qualitative analysis of the RAP process may provide insights into how practices implemented changes.
Supporting Population Health Management by Andrew Bloschichak, MD, MBA Benjamin Pease
This document discusses population health management and value-based payment models. It provides an overview of Highmark's approach, which includes pay-for-performance and accountable care organization programs. Quality and cost/utilization are measured across multiple metrics and used to determine provider payments. The goal is to shift from fee-for-service to value-based models to improve outcomes and lower costs.
AAA 2016 networking day final presentationsMike Harris
The document summarizes the results and updates from the NHS AAA Screening Programme. Some key points:
- Almost 1.3 million men were invited for screening, with an uptake of 79.5%
- Nearly 13,000 abdominal aortic aneurysms (AAA) larger than 3cm were detected, with a prevalence of 1.3%
- Options to extend surveillance intervals to biennially were presented, which could result in cost savings of over £600,000 per invited cohort.
- Evidence was presented on the risk of AAA progression in men with subaneurysmal aortas between 2.6-2.9cm, supporting potential rescreening of these men after 5 years.
This document discusses the importance of quality antenatal care. It outlines that antenatal care involves regularly monitoring the health of the mother and fetus during pregnancy. Quality antenatal care should include early registration within the first trimester, a minimum of four checkups with one by a medical officer, two tetanus injections, and 100 iron folic acid tablets. It also discusses estimating the expected number of pregnancies in an area and the importance of tracking all pregnant women.
The document discusses a study exploring the role of dietitians in multidisciplinary treatment of polycystic ovary syndrome (PCOS). The study involved a two-phase mixed methods design, beginning with an online survey of 261 healthcare providers, followed by focus groups with 9 providers. Survey results found that multidisciplinary clinics could improve access and outcomes for PCOS patients. Focus groups revealed that while dietitians play an important role in PCOS treatment, they face challenges like lack of referrals and insurance barriers. Providers felt more awareness and education are still needed on nutrition interventions for PCOS.
This document discusses a study exploring the role of dietitians in multidisciplinary treatment of polycystic ovary syndrome (PCOS). The study involved a two-phase mixed methods design, beginning with an online survey of 261 healthcare providers, followed by focus groups with 9 providers. Survey results found that multidisciplinary clinics could improve access and outcomes for PCOS patients. Barriers to multidisciplinary care included cost and differences of opinion. Focus groups revealed that while dietitians provide individualized nutrition counseling, their involvement is limited by lack of referrals and insurance coverage. Providers felt dietitians are underutilized for PCOS despite the importance of lifestyle interventions.
Elective care conference: imaging demand and capacity NHS Improvement
The document summarizes the results of demand and capacity modeling done for radiology services at Bradford Teaching Hospitals NHS Foundation Trust. The modeling found current deficits between 239-290 CT slots and 28-83 MRI slots per week to meet demand at the 65th-85th percentiles. For CT, there is also a backlog of 176-241 patients that requires clearing. The conclusions are that measuring demand, capacity, activity and backlog allows identification of bottlenecks and focus of improvement efforts, and justification of capital investments or alternate solutions to address shortfalls.
Similar to Salud Mesoamerica Initiative: Select results from the second operation measurement (20)
Este estudio evaluó la calidad de la información sobre mortalidad infantil en Yucatán, México entre 2015-2016. El análisis encontró que el sistema de registros vitales mostró buena calidad general pero con problemas en la certificación de causas de muerte, especialmente para neonatos. La concordancia entre registros médicos y estadísticas vitales varió según la causa. La Universidad de Yucatán diseñará intervenciones para mejorar la certificación de muertes infantiles.
The first phase of the “Under-5 Child Health and Mortality Statistics Project” sough to strengthen the evidence and understanding of key factors related to under-5 mortality in Yucatán, Mexico using Verbal Autopsy data collection tools with an added battery on search for care processes for U5 deaths which occurred in Yucatán during 2015-2016, and the triangulation of Verbal Autopsy reports with data from vital registration systems and medical records. This presentation, presented to stakeholders at a results dissemination workshop in October 2017 in Mérida, Yucatán, provides an overview of the project and summarizes key results and learnings from the research.
The second phase of the “Under-5 Child Health and Mortality Statistics Project” sough to strengthen the evidence and understanding of key factors related to under-5 mortality in Yucatán, Mexico through the implementation and evaluation of both community and facility-based interventions, aimed at improving recognition of alarm signs among mothers and caretakers for common causes of death in children and improving the quality of cause of death certification for deaths of children under 5, respectively. This presentation, presented virtually to stakeholders at a results dissemination workshop in January 2021, provides an overview of the project and summarizes key results and learnings from the research.
The Prospective Country Evaluation is an embedded mixed-methods evaluation platform designed to examine the Global Fund business model, investments and contribution to disease program outcomes and impact in eight countries. Findings were synthesized across the 8 countries to provide timely and actionable recommendations to support program improvements and accelerate progress towards the objectives of the Global Fund 2017-2022 Strategy.
Published in The Lancet in November 2018, GBD 2017 provides for the first time an independent estimation of population, for each of 195 countries and territories and the globe, using a standardized, replicable approach, as well as a comprehensive update on fertility. GBD 2017 incorporates major data additions and improvements, using a total of 68,781 data sources in the estimation process.
Expected human capital is a measure that combines education levels, functional health, and learning to assess a population's economic productivity. It is defined as the attributes of a population that contribute to economic growth through technology development and adoption. Expected human capital is calculated for each country by applying age-specific rates of education, health, and learning to demographic data. Higher expected human capital is correlated with higher GDP. Since 1990, many countries have improved their expected human capital through gains in education and health, leading to faster economic growth. Finland currently has the highest expected human capital while Niger, South Sudan and Chad have the lowest.
“Follow the money” in order to better understand the framework for global health governance: this presentation by Dr. Tim Mackey employs IHME-coordinated research while teaching the evolution of global health financing.
1. Maternal and child mortality in the United States has increased in recent decades according to findings from the GBD 2013 study, unlike trends in other developed nations which have seen continued declines.
2. The reasons for rising mortality in the US are unclear but may be related to increasing rates of non-communicable diseases and comorbidities among women of reproductive age as well as declining health insurance coverage and access to care.
3. While congenital birth defects have decreased substantially in the US, rates of neonatal disorders and injuries continue to outpace declines in other countries, driving higher rates of child mortality overall.
The document summarizes findings from the Saudi Health Interview Survey (SHIS) conducted in 2013. Some key findings include:
- 15.1% of Saudis ages 15 or older are hypertensive, 40.5% are borderline hypertensive
- 8.5% are hypercholesterolemic and 20% are borderline hypercholesterolemic
- 13.4% are diabetic and 16.3% are borderline diabetic
- 28.7% of Saudis are obese
This document discusses communicating population health data for impact. It notes that population health data from the Global Burden of Disease study can help answer questions about major health problems, diseases causing high mortality, diseases affecting older populations, prioritizing diseases for vaccine research, and the health burden of obesity. The data includes mortality and disability metrics for 301 diseases across 188 countries from 1990 to 2013. The goal is to share this data with global health organizations, governments, researchers, private sector groups, healthcare providers, investors, journalists, and the general public to help inform decision making. It emphasizes tailoring the sharing of data to the right audiences, formats, and timing.
The document provides an overview of the ABCE (Access, Bottlenecks, Costs, and Equity) project in Ghana which collected primary data from 240 health facilities across the country. Key findings include that while facility personnel and capacity have increased in recent years, availability of diagnostic testing and human resources vary substantially between facility types. The study also found opportunities to improve efficiency and increase service outputs given current resource levels. Results of the ABCE project can help inform health policy in Ghana by identifying areas of strength and those needing further development in the country's health system.
The document summarizes key findings from the ABCE (Access, Bottlenecks, Costs, and Equity) research project in Zambia. The project assessed facility capacity, service provision, patient perspectives, efficiency, and costs of health care delivery. It found gaps in capacity across facility types, with shortages of equipment, staff, and stock-outs of medicines and vaccines. It also found potential for improved efficiency, with the average facility using only 42% of resources. Costs per patient visit varied by facility and service type.
The document provides an overview of the Access, Bottlenecks, Costs, and Equity (ABCE) research project in Uganda. The project collected data from 247 health facilities and over 3,900 patient interviews between 2012-2013. Key findings include: gaps between reported and functional service capacity at facilities, especially for non-HIV services; high availability of HIV/AIDS services but lower availability for non-communicable diseases; and efficiency scores varied widely both across and within facility platforms, indicating potential for expanded service provision.
The ABCE project in Kenya collected data from 254 health facilities and over 4,200 patient exit interviews from 2012. Key findings include:
- Primary care facilities reported providing services but often lacked full capacity, especially in rural areas. Equipment, staffing, and diagnostic capacities were often inadequate.
- Patients generally paid some fees but amounts varied. Over 75% of public health center patients paid 20 KSH or less.
- Efficiency scores averaged 41% and generally declined with lower levels of care. Significant potential existed to increase service production given resources.
- Costs per patient visit varied by facility and output, with outpatient visits generally the lowest cost.
The document discusses vital records and their importance as inputs for measuring population health through studies like the Global Burden of Disease. It describes how the Institute for Health Metrics and Evaluation uses vital registration data from over 130 countries, along with other sources, to measure mortality trends and causes of death globally. Challenges with obtaining and standardizing vital records data are addressed, such as accounting for garbage codes, and opportunities for future collaboration on analyzing vital records at subnational levels in countries like the United States are presented.
The document discusses how the Institute for Health Metrics and Evaluation at the University of Washington uses maps and spatial analysis to inform global health decision making. It summarizes their work on the Global Burden of Disease study which quantifies health loss from diseases, injuries and risk factors in 187 countries. It describes how they measure and analyze data inputs, manage missing data, use covariates and risk factors, conduct spatial-temporal regression, and perform small area estimation to analyze health patterns at subnational levels. Remaining challenges include adding more spatial covariates and conducting disease burden studies at local levels.
The document summarizes key points from the International Open Government Data Conference. It discusses the objectives of the conference, which was to share lessons learned about open government data and demonstrate its power. It also outlines some of the benefits of open data, such as improving accountability and creating economic opportunities. Finally, it emphasizes that successfully implementing open government data requires focusing on creating an ecosystem around the data through activities like skills training, prototyping, and scaling successful projects.
The document summarizes the work of the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. IHME is a global health research institute funded by the Bill & Melinda Gates Foundation that aims to improve population health by providing rigorous analysis and measurements of global health data. IHME manages large quantities of health data from various sources to produce estimates on diseases, risk factors, and measures like disability-adjusted life years. IHME is developing solutions like its Global Health Data Exchange to improve access, transparency, and use of health data through standardized metadata and data sharing.
The Institute for Health Metrics and Evaluation is a global health institute that provides scientific measurements and evaluations of population health. It collects various types of health-related data, including social determinants, risks factors, population surveys, and facility data. However, health data is often difficult to access due to issues like privacy, capacity, and a sense of ownership. Health Data Innovation is changing this by encouraging data sharing through open data portals, funding for innovation, and engaging individuals to manage and share their own health data. This enables a virtuous cycle where more data is collected and shared, fueling further innovation and making more timely data available.
More from Institute for Health Metrics and Evaluation - University of Washington (20)
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Salud Mesoamerica Initiative: Select results from the second operation measurement
1. Salud Mesoamerica Initiative:
Select results from the second
operation measurement
November 8, 2018
Ali H. Mokdad, Ph.D.
Chief Strategy Officer of Population Health
Director, Middle Eastern Initiatives
Professor, Global Health
6. Activity flowchart
Study and survey design (IHME)
• Fact-finding visits
• Instrument design
• CAPI (real-time data collection)
• Training and pilots
• Sampling
• Quality checks
Data collection (in-country agencies)
• Community census
• Household survey
• Health facility survey
• Supervision by IHME
Analysis (IHME)
7. Census
• Full household listing for selected
segments
• Strict protocol for visits
• Response rates monitored
• Unique IDs assigned for reference
during household survey
• Manual checking to map if
discrepancies found in data
• All household members accounted
for along with data on age, sex,
relationship to head of household,
and languages spoken
7
Honduras, May 2017
8. Household Survey
• Household characteristics
• Expenditure and health expenditure
• Health service utilization (women and
children)
• Family planning, reproductive history
• Child health, breastfeeding, immunization
• Physical measurements
o Weight, height, hemoglobin
• Dried blood spots (DBS) in Chiapas
• Water quality in Panama
Honduras, May 2017
9. Health Facility Survey
• Questionnaire administered to facility
manager
• Physical observation
o Equipment and inputs
o Pharmaceuticals
o Review of registries to detect stock outs
o Posters and health promotion materials
• Medical record review
o Record quota according to characteristics
of health unit
─ Antenatal and postnatal care
─ Deliveries
─ Maternal and neonatal complications
─ Child growth and development, deworming
Nicaragua, May 2017
10. Data Quality Control
• Fact finding visits to refine and
adapt surveys as needed
• IHME staff remained in field
following training and piloting in
order to launch data collection
• Return supervision visits mid-data
collection
• Continuous communication with field
teams and real-time data verification
• Weekly IHME review of indicator
performance and subcomponents
• Every census segment approved by
faculty before household survey
begins 10
Nicaragua fact finding, May 2017
12. SMI 36-Month Challenges
• Sample size and confidence interval
• Increased disparities
• Unrest and no trust in government
• Economic hardship
• Some indicators redefined after the baseline to align with
country norms, clinical best practices, and to better measure
an indicator.
12
13. SMI 36-Month Challenges
Align with norm: fundal height only measured for ANC visit if
gestational age is >=14 weeks in El Salvador
• In the first round of MRR measurement in El Salvador, the recording
of fundal height was required at all ANC visits to pass the indicator for
ANC with quality.
• However, it was determined that fundal height was only supposed to
be checked at visits where the woman was >=14 weeks gestation and
thus the indicator definition needed to be revised.
• To account for this change in definition, we recomputed the indicator
value using this new restriction on the previously collected data.
• By removing this requirement to align with the norm, the value
increases by 8.2% for the MRR baseline and increases by 8.8% for
the follow-up.
13
14. SMI 36-Month Challenges
Clinical best practice: updated laboratory tests/ medicines
required for appropriate management of complications
• The original neonatal complications baseline survey in Guatemala did
not capture all exams and checkups that are necessary to manage
asphyxia, including APGAR score, heart rate, and many types of
oxygen and heat application.
• After review, the definitions and surveys were updated and medical
records were recollected for the baseline time period.
• For example, now oxygen and heat should only be applied if the
APGAR score at 5 minutes is <=3, and heart rate is used as an
alternative to the pulse.
• Instead of only 46.7% of medical records passing the original indicator,
85% are now passing the recollected baseline records because the
definition was better tailored to the complication.
14
15. SMI 36-Month Challenges
Better measure it: name or signature did not allow us to know
if a doctor provided care or not.
• The Belize MRR indicator for immediate postnatal care required a
checkup by the appropriate personnel (doctor/nurse/midwife) at
baseline in order to pass.
• After review, it was determined that it isn’t always possible to know who
cared for the neonate through the medical record documentation.
• Thus, this indicator component was removed and increased the original
baseline value by 2.3%. By removing this requirement from the second
follow-up definition, the value increases by 8.8%.
15
16. Recollection of Baseline Medical Records
• Some challenges
encountered to access
records from full baseline
time period
• Some changes in record
numbering systems that
made it difficult to sample
• Amount of files meant 5 years
storage and rest to
warehouses
18. SMI 36-Month Challenges
• Lower response rate
• Folks moving to safer areas
• Active files and those with complications are available
• Not able to post-stratify for movement and timeframe of baseline
meant our results for baseline are overestimates and results for
36-month are underestimated
18
20. Sample description – Households
Baseline # HH 36-month # HH
Intervention Comparison Intervention Comparison
Honduras 1,540 1,458 1,683 756
El Salvador 3,625 n/a 1,029 n/a
Nicaragua 1,300 770 1,853 774
Belize* 351 n/a 434 n/a
Mexico 3867 1543 1703 760
Guatemala 3533 872 1896 750
Panama 2195 n/a 1538 n/a
Costa Rica** 41 n/a 62 n/a
Total 16,060 4,643 9,702 3,040
*Lot Quality Assurance Sampling instead of census and household survey; number of women respondents
listed (not included in total row of households) ** Schools (not included in total row of households)
20
26. Honduras Performance Indicator Results
1 The baseline only captured fetal heart rate, fetal movement, and uterine height at the first visit if at the appropriate gestational age. RPR was not captured at baseline as an alternative
to VDRL lab test. The original baseline value was 23.7%. To ensure comparability across rounds, the baseline estimate was recalculated to 23.2%.
2 The original baseline value was 51.1%. To ensure comparability across rounds, the baseline estimate was recalculated to 59.2%.
3 Baseline & first follow-up did not capture heart rate as an alternative to pulse.
4 Data from medical records from the baseline timeframe of complications were recollected during the 36-month evaluation. Indicator values and definitions have been updated
accordingly.
5 Original baseline value was 71.8%. This indicator was recalculated due to a change in the indicator definition to include any visit within 2 days rather than limited to only visits at exactly
2 days.
6 Zinc was not captured and thus the baseline cannot be calculated
Target Passing
% CI % CI % CI % CI % CI
3030
4 ANC with quality1
MRR 23.2% (16 - 32) 66.1% (60 - 72) 94.1% (91 - 97) 43.1% (30 - 57) 58.2% (47 - 69) 33.7% YES
3040
ANC within first trimester2
MRR 59.2% (50 - 68) 63.6% (57 - 70) 89.7% (86 - 93) 60.3% (47 - 73) 69.7% (58 - 80) 63.1% YES
4010
Institutional delivery
HH 68.6% (61 - 76) 84.7% (78 - 89) 69.4% (63-75) 77.9% (70-85) 76.6% YES
4030
Postpartum checkup within 7 days
HH 47% (40 - 54) 60.4% (53 - 67) 51.7% (46-58) 73.0% (61-82) 57.0% YES
4050
Immediate postpartum care for
women3
MRR 67.5% (60 - 75) 28.6% (18 - 41) 91.2% (85 - 95) 70% (59 - 79) 76.8% (70 - 83) 80% YES
4065
Partograph filled according to the
norm MRR 91.3% (84 - 96) 97.9% (93 - 100) 99.1% (95 - 100) 80% YES
4070
Neonatal complications managed
according to the norm4
MRR 10% (4 - 20) 42.9% (32 - 54) 7.8% (3 - 16) 6.3% (2 - 14) 36.9% YES
4080
Obstetric complications managed
according to the norm4 MRR 38.5% (29 - 48) 62.7% (55 - 70) 26.4% (18 - 36) 49.6% (41 - 58) 51% YES
4140
Children 0-59 months with pneumonia
follow-up within two days5
MRR 87% (80 - 92) 61.5% (53 - 70) 95.3% (91 - 98) 92.2% (83 - 97) 83.3% (73 - 91) 79.8% YES
5060
Children 0-59 months with diarrhea
treatment according to the norm6
MRR 39% (33 - 46) 95.3% (92 - 98) 68.3% (58 - 77) 50% YES
5070
Micronutrient consumption
HH 0.1% (0 - 1) 29.5% (24 - 36) 0.0% - 2.4% (1-7) 15.1% YES
Indicator short decription
Data
source Second Follow-up (2017)
Baseline (2013)
n/a
n/a
n/a
n/a
n/a
n/a
n/a
First Follow-up (2014)
#
Intervention
n/a
n/a
Baseline (2013) Second Follow-up (2017)
Comparison
33. Honduras Conclusions
• Honduras met all 36-month performance targets
• Impressive progress in indicators in intervention areas
compared to comparison areas
• Honduran MoH very engaged this round
• Some indicators with especially promising results:
o Antenatal care coverage and with quality
o Institutional delivery
o Management of complications
o Micronutrient consumption
33
36. Belize Performance Indicator Results
Target Passing
% CI % CI % CI
2500 Contraception post-delivery 4.8% (0 - 24) 0% (0 - 9) 90.3% (83 - 95) 17.0% YES
3040 ANC within first trimester1
31.8% (14 - 55) 29.7% (22 - 38) 39.9% (32 - 48) 29.8% YES
4030 Postpartum care for woman within 7 days2
41.7% (26 - 59) 75.4% (64 - 85) 37.8% YES
4070 Neonatal complications3
23.7% (15 - 35) 53.5% (41 - 66) 37.5% YES
4080 Obstetric complications3
21.8% (13 - 33) 33.3% (23 - 45) 37.6% YES
4095 AMTSL (oxytocin)4
60% (32 - 84) 80% (70 - 88) 98.7% (95 - 100) 49.1% YES
4103 Immediate postpartum care for neonates5
30.2% (17 - 46) 86.8% (76 - 94) 88.7% (83 - 93) 39.4% YES
4410 Growth & development checks 69.6% (63 - 76) 37.5% YES
4420 Child services enrollment within 7 days 25.3% (17 - 36) 17.0% (11 - 24) 66.5% (59 - 73) 35.3% YES
5135 Diarrhea (0-59m) treatment 20% (1 - 72) 95.3% (91 - 98) 80.0% YES
Indicator short decription
#
Intervention
Baseline (2013) First Follow-up (2014) Second Follow-up (2017)
n/a
n/a
n/a
n/a
N/A n/a
1 The original baseline value was 22.8%. Due to redefinition of the indicator, the recalculated baseline value increased above the absolute target value. The original target
for a 7 percentage point increase from baseline was still met.
2 The original baseline value was 22.8%. Due to redefinition of the indicator, the recalculated baseline value increased above the absolute target value. The original target
for a 15 percentage point increase from baseline was still met.
3 Data from medical records from the baseline timeframe of complications were recollected during the 36-month evaluation. Indicator values and definitions have been
updated accordingly.
4 The original baseline value was 34.1%. Due to redefinition of the indicator, the recalculated baseline value increased above the absolute target value. The original target
for a 15 percentage point increase from baseline was still met.
5 The original baseline value was 19.4%. Due to redefinition of the indicator, the recalculated baseline value increased to 30.2%. The original target for a 20 percentage
point increase from baseline was still met.
38. Belize 4103: Neonates managed according
to the norm
38
*Only measured at hospitals (N=4); each column represents one hospital
39. Belize 4095: Oxytocin/ uterotonic
administration following delivery
39
N % N % N %
Oxytocin was administered after birth 15 53.3 90 80 156 98.7
Other uterotonic was administered
after birth 15 6.7 90 2.2 156 1.9
Oxytocin/other uterotonic was
administered after delivery 15 60 90 80 156 98.7
Baseline First Follow-up Second Follow-up
40. Belize 4420: Newborn children enrolled in
child services in <=7 days after birth
40
41. Belize Conclusions
• Belize met all 36-month performance targets
• Impressive progress in indicators
• Some indicators with very promising results :
o Management of complications
o Postpartum care
o Child enrollment
o Diarrhea treatment
• Even though targets were met, there is more work to do for
some indicators
o Early catchment of ANC
41
44. El Salvador Performance Indicator Results
Target Passing
% CI % CI % CI
1060
Children 6-23 mo with hemoglobin
measurements < 110 g/L 47.0% (44 - 50) 47.3% (36 - 59) 36.5% YES
2010
Current use of modern Family Planning
Method 53.9% (51 - 57) 75.0% (70-79) 60.5% YES
3030
4 ANC with Quality3
51.4% (44 - 59) 63.9% (58 - 70) 62.5% YES
3041
ANC within first trimester4
58.7% (51 - 66) 74.6% (69 - 79) 74.9% YES
4010
Most recent birth in last 2 years in-facility
and attended by SBA 85.7% (82 - 88) 98.3% (96 - 99) 94.2% YES
4031
Postpartum checkup one week after
delivery5 81.2% (78 - 84) 62.6% (53 - 71) 91.6% NO
5025
Children 12-23 months vaccinated for
MMR according to vaccination card 65.5% (61 - 70) 91.1% (83 - 95) 73.6% YES
5030
Children 12-59 mo who received 2
deworming doses in past year 36.2% (33 - 39) 40.5% (35 - 46) 56.4% NO
5060
Mothers who gave their children ORS and
zinc during last episode of diarrhea 4.5% (3 - 7) 33.7% (21 - 49) 24.4% YES
8380
Completed birth plan at an Ecos facility6
86.3% (82 - 90) 70% YES
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
n/a
# Indicator short decription
Intervention
Baseline (2011)1
First Follow-up (2014)2
Second Follow-up (2017)
1 Baseline weights have been recomputed in accordance with updated methodology.
2 Medical records were not reviewed during baseline data collection. Medical record review results from the first follow-up measurements
serve as a baseline for El Salvador.
3 Referral to another facility for ANC care was not captured in the record at the first follow-up
4 Reported gestational age was used at the second follow-up, while calculated gestational age was used at the first follow-up
5 At baseline, women were asked one question regarding postpartum checkup one week after delivery; at the second follow-up, women were
asked to report on every postpartum checkup they received in the first six weeks after delivery. The indicator calculation at second follow-up
incorporated responses from these additional questions for compliance of postpartum check.
6 Indicator was only measured at second follow-up.
51. El Salvador 4010: Institutional delivery –
national versus SMI area trends
51
52. El Salvador Conclusions
• El Salvador met 8/10 of the 36-month performance targets
• Impressive progress in most indicators
• Some indicators with very promising results:
o Timely prenatal care
o Institutional delivery with qualified personnel
o Use of family planning methods
o Treatment of diarrhea with ORS / zinc
• There is more work to do for some indicators
o Postpartum care coverage
o Anti-parasitic treatment
o Reduction of anemia
52
56. Costa Rica sample: breakdown by grade
56
n % n %
7th grade 241 26.1 461 21.8
8th grade 220 23.8 458 21.6
9th grade 217 23.5 398 18.8
10th grade 203 22 415 19.6
11th grade 43 4.7 387 18.3
Total 924 2119
Baseline 2013 Second Follow-Up 2018
57. Indicator 8: Knowledge of correct use of modern
contraception methods
Sexually active students
N % SE N % SE
Sexually active students 237 11.6 3.3 570 26.6 4.3
7th grade sexually active 33 0 - 45 4.9 4.9
8th grade sexually active 50 2.2 1.9 74 32.6 6.4
9th grade sexually active 70 21.9 13 108 30.9 11.1
10th grade sexually active 69 5.2 2.7 159 20 4.9
11th grade sexually active 15 35.2 12.1 184 32.3 8.7
Baseline 2013 Second Follow-Up 2018
Not sexually active students
N % SE N % SE
NOT sexually active students 648 2.4 0.7 1348 8.1 2.1
7th grade NOT sexually active 194 1.2 0.9 344 5.3 2.5
8th grade NOT sexually active 157 0.2 0.2 343 5.2 1.6
9th grade NOT sexually active 140 3.7 2.1 258 13.6 3.2
10th grade NOT sexually active 132 8 3.4 224 10.3 3.8
11th grade NOT sexually active 25 7 5.6 179 13.5 5.4
Second Follow-Up 2018
Baseline 2013
57
58. Indicator 9: Requested and received contraception at
an EBAIS, if student noted having attended an EBAIS
Sexually active students
N % SE N % SE
Sexually active students 41 92.5 5.2 166 94.6 2.2
7th grade sexually active 11 100 - 15 99.4 0.7
8th grade sexually active 11 100 - 25 85.1 7.9
9th grade sexually active 10 93.4 6.1 33 100 -
10th grade sexually active 7 73.3 22.1 44 96.6 2.9
11th grade sexually active 2 100 - 49 90.9 3.4
Baseline 2013 Second Follow-Up 2018
Not sexually active students
N % SE N % SE
NOT sexually active students 25 47.4 19.3 104 70.6 8
7th grade NOT sexually active 6 6.2 6.5 31 60 14.1
8th grade NOT sexually active 10 78.4 12.9 22 59.2 15.6
9th grade NOT sexually active 4 84.7 17.2 13 81.1 10.2
10th grade NOT sexually active 5 57 23.2 18 87 9.3
11th grade NOT sexually active 0 - - 20 62.1 11
Second Follow-Up 2018
Baseline 2013
58
59. Indicator 10: Current use of modern contraception by
sexually active student or partner, among students
who reported being sexually active in the past 6
months
59
N % SE N % SE
Sexually active students 162 74 7.4 361 71.6 3.8
7th grade sexually active 22 91 7.6 21 61.1 12.9
8th grade sexually active 41 59.9 11.8 45 80.9 9.8
9th grade sexually active 43 70 15.9 68 78.8 8.4
10th grade sexually active 46 79.3 6.6 98 47.9 12.6
11th grade sexually active 10 82.6 13.6 129 82 5.6
Second Follow-Up 2018
Baseline 2013
60. Costa Rica Conclusions
• Costa Rica met 1/3 of the IHME measured performance
targets
• Despite not meeting targets, progress seen especially in
knowledge and receipt of contraception methods
• More work to do to improve use of contraceptives
60
63. Guatemala Performance Indicator Results
1MRR indicators 4050, 4070 & 4080 displayed above for the second follow-up include records from only a 20 month time period after interventions were completed.
If the medical record time frame was extended to a 2 year time period (24 months), the values for the second follow-up intervention facilities would be the following:
4050: 40.6%, 4070: 7.2%, 4080: 21.0%.
2Definition redefined for 36-months
3Indicator excludes caesarean sections and deliveries outside of Guatemala; this baseline indicator recalculation changed the original target from 56.1% to 58.6%
Target Passing
% LB UB % LB UB % LB UB % LB UB
2080
Women who have received FP information from
a community health worker (partnered only)
HH
17.6% 14.8% 20.7% 16.7% 13.7% 20.2% 22.8% 16.8% 30.2% 21.8% 15.0% 30.5% 32.4% FAIL
4015
Women who delivered in a CAP, CAIMI, or
hospital [no skilled attendant criterion] for most
recent birth in the last two years
HH
19.3% 15.7% 23.5% 27.0% 21.7% 33.1% 29.5% 21.2% 39.6% 25.4% 17.7% 35.0% 23.7% PASS
4050
4 postpartum checks in the first hour after birth,
and 2 postpartum checks in the second hour
after birth1
MRR
13.0% 8.3% 19.2% 37.1% 30.6% 44.1% 25.5% 13.9% 40.3% 29.2% 21.2% 38.2% 28.0% PASS
4070
Management of neonatal complications
according to the norm1 MRR
13.7% 8.2% 21.0% 9.5% 5.6% 14.8% 14.3% 5.4% 28.5% 5.8% 1.9% 13.0% 16.0% FAIL
4080
Management of obstetric complications
according to the norm
1 MRR
14.5% 9.1% 21.5% 21.8% 16.0% 28.6% 23.3% 11.8% 38.6% 25.3% 16.2% 36.4% 27.4% PASS
4100
Neonatal postpartum care within 48 hours after
birth, in-facility with doctor, nurse, or auxiliary
nurse
HH
8.6% 6.8% 10.7% 19.9% 15.6% 25.1% 13.7% 8.7% 20.9% 21.4% 16.2% 27.7% 13.6% PASS
4660
Births attended to in CAPs and CAIMIs that
followed best practices2 MRR
50.0% 37.6% 62.4% 96.6% 92.3% 98.9% 44.7% 28.6% 61.7% 88.7% 77.0% 95.7% 70.0% PASS
4670
Women whose institutional birth (CAP, CAIMI,
or hospital) met at least two of five identified
standards for cultural sensitivity3
HH
38.6% 30.7% 47.1% 49.4% 39.5% 59.2% 44.5% 33.0% 56.6% 56.6% 40.6% 71.4% 58.6% PASS
5060 Treatment of diarrhea with ORS and zinc HH 0.4% 0.1% 1.7% 9.3% 5.7% 14.6% 3.2% 0.9% 10.8% 14.7% 6.7% 29.3% 10.4% PASS
5070
Children who have received 60 packets of
micronutrients in the past 6 months2 HH
1.5% 0.9% 2.5% 6.0% 3.6% 9.8% 5.2% 3.3% 7.9% 4.0% 1.9% 8.4% 37.5% FAIL
Comparison
Baseline (2013) Second Follow-up (2018)
# Indicator short description
Data
source
Intervention
Baseline (2013) Second Follow-up (2018)
36M
65. Guatemala 4015: In-Facility Delivery
19.3
21.7
19.2
27.0
29.9
26.6
0
10
20
30
40
50
60
70
80
90
100
Delivered in facility (CAP, CAIMI,
hospital)
Delivered withskilledattendant Delivered in facility witha skilled
attendant
%
of
women
Indicator 4015: Institutional delivery, most recent birth in last two
years
Baseline Second follow-up
*Intervention areas only
65
66. Guatemala 4670: Culturally sensitive delivery
34.8
38.6 38.6
41.7
49.1 49.4
0
10
20
30
40
50
60
70
80
90
100
2 attributes of cultural pertinence met 2 attributes met, excluding C-section
births
2 attributes met, excluding C-section
births and births in Mexico
%
of
women
Indicator 4670: Culturally sensitive delivery, most recent birth in
last two years
Baseline Second follow-up
*Intervention areas only
66
67. Guatemala 4100: Skilled neonatal postpartum
care within 48 hours of birth
15.8
10.3 12.5
8.6
39.2
22.7
28.4
19.9
0
10
20
30
40
50
60
70
80
90
100
Any postnatal check infirst
week
Skilled postnatal check in-
facility within 7 days
Skilled postnatal check, eldest
children only
Skilled in-facility check within
48 hours
%
of
women
Indicator 4100: Skilled neonatal postpartum care within 48 hours of
birth
Baseline Second follow-up
*Intervention areas only
67
68. Guatemala 5070: Receiving micronutrients
20.8 19.2
1.5
37.6
35.1
6
0
10
20
30
40
50
60
70
80
90
100
Received any doses Consumed any doses Received at least 60 doses
%
of
children
Indicator 5070: Children who have received 60 packets of micronutrients
in past 6 months
Baseline Second follow-up
*Intervention areas only
68
69. Guatemala 4050: Immediate maternal PPC
Intervention
Guatemala - Baseline
All appropriate blood pressure checks
All appropriate temperature checks
All appropriate heart rate/pulse checks*
I4050
* Heart rate not captured as pulse alternative at baseline
Guatemala - Second Follow-up
All appropriate blood pressure checks
All appropriate temperature checks
All appropriate heart rate/pulse checks
I4050
Comparison
Guatemala - Baseline
All appropriate blood pressure checks
All appropriate temperature checks
All appropriate heart rate/pulse checks*
I4050
* Heart rate not captured as pulse alternative at baseline
Guatemala - Second Follow-up
All appropriate blood pressure checks
All appropriate temperature checks
All appropriate heart rate/pulse checks
I4050
Indicator Requirements:
Patient was checked for blood
pressure + temperature + heart
rate/pulse four times in the first
hour after delivery, twice in the
second hour, and once at
discharge
69
70. Guatemala 4660: delivery management
performance by municipality
*Intervention areas only
Indicator Requirements: Patient
was attended by doctor / nurse /
obstetrician / midwife + administration
of oxytocin or other uterotonic +
partograph included in the medical
record + cord clamping occurs
between 2-3 minutes after delivery
**Value over municipality represents the
number of medical records evaluated 70
Baseline 2nd follow-up
71. Guatemala 4080: Management of
complications according to the norm
Obstetric complications
N % CI N % CI
Obstetric complications managed
according to the norm in the last two
years
138 14.5 (9.1 - 21.5) 179 21.8 (16 - 28.6)
Baseline Second Follow-Up
Neonatal complications
N % CI N % CI
Neonatal complications managed
according to the norm in the past two
years
124 13.7 (8.2 - 21.0) 179 9.5 (5.6 - 14.8)
Baseline Second Follow-Up
71
72. Guatemala Conclusions
• Guatemala met 7/10 of the 36-month performance targets
• Despite not meeting targets, progress was observed,
especially for ANC, institutional delivery, and postpartum care
• There is more work to be done, and indicator results in general
are lower than what is observed in other SMI countries
• Challenges with medical record sampling and storage of
records
72
74. Nicaragua Performance Indicator Results
1 The baseline value was previously reported at 37.3%. To ensure comparability across rounds, the baseline estimate was recalculated to 39.6%. Baseline uses calculated
gestational age while follow-ups use recorded gestational age.
2 The second follow-up survey included an additional question that asked if women were checked before discharge after delivering in facility. If a women was checked before
discharge, she was considered to have passed this indicator per definition. Due to the addition of this question, the baseline and follow-up values are not strictly comparable.
3 Data from medical records from the baseline timeframe of complications were recollected during the second follow-up evaluation. Indicator values and definitions have been
updated accordingly.
4 Baseline did not capture result of the pregnancy (live or stillbirth), so records could not be excluded based on this criteria.
5 This indicator was not captured at the baseline & first follow-up evaluations.
6 The baseline value was previously reported at 47.3%. To ensure comparability across rounds, the baseline estimate was recalculated to 43.5%.
76. 4030: Postpartum care within 10 days
76
*Intervention areas at second follow-up only; includes check before discharge at in-facility delivery
77. 4103: Immediate PPC for neonates in a
health facility after their birth
N % N % N %
Vitamin K 69 95.7 184 98.9 279 92.5
Application of prophylaxis with oxytetracycline
ophthalmic/chloramphenicol 69 91.3 184 98.9 279 92.1
Curing the umbilical cord with water and
chlorhexidine 69 55.1 184 96.2 279 68.8
Evaluation for the presence of malformations 69 92.8 184 93.5 279 88.9
BCG vaccine 69 75.4 184 90.2 279 88.2
APGAR score (at 1 or 5 minutes) 69 100 184 100 279 94.3
Respiratory rate 69 26.1 184 78.3 279 58.8
Weight 69 95.7 184 98.9 279 92.1
Height 69 94.2 184 92.4 279 91.4
Head circumference 69 88.4 184 91.3 279 91
Appropriate immediate postpartum care for
neonates 69 7.2 184 67.9 279 43.7
Baseline 1st Follow-up 2nd Follow-up
*Intervention areas only
77
78. 5025: MMR vaccine according to
vaccination card (12-23 months)
*Intervention areas only
78
79. 4070: Management of Neonatal Complications
- asphyxia
N % N %
Vital signs checked: 11 63.6 30 93.3
Heart rate/pulse 11 81.8 30 96.7
Respiratory rate 11 63.6 30 93.3
APGAR at 1 minute 11 72.7 30 96.7
APGAR at 5 minutes 11 72.7 30 96.7
Laboratory tests: 11 27.3 30 40
Glucose 11 27.3 30 40
Oxygen saturation (if severe asphyxia) 1 0 1 0
Heat application 11 36.4 30 60
Oxygen administration (if severe asphyxia) 1 0 1 0
One of the following (if severe asphyxia): 1 100 1 100
Ambu (positive pressure ventilation) 1 100 1 100
Cardiac massage 1 0 1 0
Tracheal intubation 1 0 1 0
Evaluated by a doctor 11 72.7 30 86.7
Referred to a complete facility (if severe asphyxia &
neonate did not die in the facility) 1 100 1 100
Asphyxia managed according to the norm 11 18.2 30 20
2nd Follow-up
Baseline
Basic
*Intervention areas only
N % N %
Vital signs checked: 24 95.8 10 100
Heart rate/pulse 24 100 10 100
Respiratory rate 24 100 10 100
APGAR at 1 minute 24 95.8 10 100
APGAR at 5 minutes 24 95.8 10 100
Laboratory tests: 24 87.5 10 60
Glucose 24 87.5 10 60
Oxygen saturation (if severe asphyxia) 0 0
Heat application 24 70.8 10 80
Oxygen administration (if severe asphyxia) 0 0
One of the following (if severe asphyxia): 0 0
Ambu (positive pressure ventilation) 0 0
Cardiac massage 0 0
Tracheal intubation 0 0
Evaluated by a doctor 24 100 10 100
Asphyxia managed according to the norm 24 62.5 10 60
Complete
Baseline 2nd Follow-up
79
80. 4080: Management of Maternal Complications
– hemorrhage
N % N %
Vital signs checked: 54 92.6 114 97.4
Pulse/heart rate 54 92.6 114 99.1
Blood pressure 54 98.1 114 97.4
Medications administered (at least one of the following): 54 83.3 114 84.2
Ringer's Lactate/Hartmann's solution 54 70.4 114 43.9
Saline Solution 54 59.3 114 69.3
Appropriate management of specific causes of hemorrhage 32 78.1 60 65
Hemorrhage managed according to the norm 54 75.9 114 70.2
Basic
Baseline 2nd Follow-up
*Intervention areas only
N % N %
Vital signs checked: 45 100 19 100
Pulse/heart rate 45 100 19 100
Blood pressure 45 100 19 100
Medications administered (at least one of the following): 45 93.3 19 84.2
Ringer's Lactate/Hartmann's solution 45 66.7 19 63.2
Saline Solution 45 57.8 19 63.2
Laboratory tests: 45 20 19 63.2
Hematocrit 45 88.9 19 100
Hemoglobin 45 20 19 63.2
Platelets 45 80 19 100
Appropriate management of specific causes of hemorrhage 18 94.4 12 75
Hemorrhage managed according to the norm 45 17.8 19 52.6
Complete
Baseline 2nd Follow-up
80
81. Nicaragua conclusion
• SMI shows great progress in Nicaragua
• Some indicators show promising results:
o Timely antenatal care
o Use of family planning methods
o Management of complications
o Postpartum care with qualified personnel
• There is room to improve for some indicators:
o Deworming treatment
o Information about family planning by health facilty personnel or
community health workers
81
84. Panama Performance Indicator Results
1. Redefined to count women who underwent sterilization as in need of and using contraception, and women who are infertile or desire pregnancy as not in need of
contraception.
2. As at baseline definition, women who didn't know how many ANC checks they had or didn't know who attended them are counted as zero. If excluding "don't know" responses:
baseline 51.6%(CI 45.1-58), follow-up 35.9% (CI 28.7-43.7).
3. MRR indicators 3040 & 4095 displayed above for the second follow-up include records from only a 22 month time frame after interventions were completed. If the medical
record time frame was extended to a 2 year time period (24 months), the values for the second follow-up facilities would be the following: 3040: 31.3%, 4095: 85.5%. The original
3040 baseline value included doctor/nurse requirement at the first visit, but that requirement is now excluded.
4. Original baseline in performance matrix was rounded to 1%.
Target Passing
% LB UB % LB UB
2020 Unmet need for contraception
1
HH 90.0% 85.2% 93.4% 98.8% 97.6% 99.5% 84.3% FAIL
3020
4 prenatal care visits with doctor or professional
nurse
2 HH
38.3% 33.3% 43.5% 24.2% 19.2% 30.0% 53.3% FAIL
3040 First prenatal check before 13 weeks gestation
3
MRR 37.3% 29.8% 45.2% 31.2% 26.9% 35.8% 46.4% FAIL
4020
Maternal postpartum care within 48 hours after
birth, with doctor or professional nurse
HH
13.4% 10.2% 17.3% 10.9% 7.7% 15.2% 28.4% FAIL
4095 Application of oxytocin3
MRR 78.3% 71.1% 84.5% 85.4% 81.0% 89.1% 85.0% PASS
4100
Neonatal postpartum care within 48 hours after
birth, in-facility with doctor or
professional/auxiliary nurse
HH
10.8% 8.1% 14.3% 16.7% 12.3% 22.3% 20.8% PASS
5025
MMR vaccination according to card for children
12-24 months old
HH
69.1% 62.2% 75.2% 71.0% 65.7% 75.8% 76.1% FAIL
5030
Children with at least 2 deworming treatments
in the past year
HH
8.7% 6.7% 11.2% 12.9% 10.2% 16.2% 38.7% FAIL
5060 Treatment of diarrhea with ORS and zinc HH 0.6% 0.1% 4.0% 6.2% 2.2% 16.4% 20.6% FAIL
5710 Adequate water quality
4
HH 0.9% 0.1% 6.4% 0.0% 0.0% 0.0% 16.0% FAIL
Data
source 36M
Intervention
Baseline (2013) Second Follow-up (2018)
# Indicator short description
86. Panama 2020: Unmet need for contraception
86
83.9
85.7
90.0
86.9
98.3 98.8
0
10
20
30
40
50
60
70
80
90
100
In needof contraception Using no method, among women in
need
Using no modern method, among
women inneed
%
of
women
Indicator 2020: Unmet need among women in need of
contraception
Baseline Second follow-up
87. Panama 3020: 4 ANC visits
87
85.5
36.9
51.6
38.3
59.5
28.7
35.9
24.2
0
10
20
30
40
50
60
70
80
90
100
Any ANC visit 4 skilled ANC visits, among
primiparous women
4 skilled ANC visits, don't
know responses excluded
4 skilled ANC visits
%
of
women
Indicator 3020: 4 prenatal care visits, most recent birth in last two
years
Baseline Second follow-up
88. Panama 4020: Maternal postpartum care
88
51.9
29.7
18.5
13.4
50.6
26.3
20.4
10.9
0
10
20
30
40
50
60
70
80
90
100
Any check in first 6 weeks Skilled check within 7-42
days
Skilled check within 7 days Skilled check within 48 hours
%
of
women
Indicator 4020: Maternal postpartum care within 48 hours with
qualified personnel, most recent birth in last two years
Baseline Second follow-up
89. Panama 5025: MMR vaccination according to
card for children 12-24 months old
89
83.5
61.0
69.1
88.2
76.6
71.0
0
10
20
30
40
50
60
70
80
90
100
Received MMR vaccine, recall or card Received MMR vaccine, recall only Received MMR vaccine, card only
%
of
children
Indicator 5025: MMR vaccine according to card, for children 12-24
months old
Baseline Second follow-up
90. Panama 5710: Adequate water quality
• Requirements:
• Positive for chlorine
• Negative for coliforms
• Zero cases tested were both
positive for chlorine and
negative for coliforms
• Shown: A test for E. Coli and
coliforms, which turns blue-
green if positive. The test on
the far left has incubated for
24 hours, and the ones in the
middle and far right have
incubated for 12 hours.
90
91. Culture against family planning
• Guna leaders originally vetoed the family planning survey sections.
o Consider contraception use a genocidal crime and that goes against their
population growth objectives.
o Fear of promotion of family planning as a way to reduce their population.
o Traditional line of communication established to inform pregnancy, the first
in this line is the healer before the family, therefore consider disrespectful
that a stranger comes to investigate women about pregnancy and
abortions.
o They also expressed concern that with these questions they could judge
their traditional medicine badly.
• After further explanations and discussions around these questions,
there was agreement to include these questions to provide key
information to implement services aimed at preventing maternal
and child deaths.
92. Feeling of marginalization
• In meeting with the Congress of the
Guna Yala Culture (June 13 & 14),
they indicated a desire to be involved
in planning of the operation.
• Road blockade of Guna people,
protesting lack of water services
(encountered during pilot)
93. Complaints about services
• When approached for the follow-up survey, communities complained
they had no information about the Initiative from the MoH
• In a meeting, community representatives and liaison from the MoH
were just exchanging contact data, what made evident the lack of
previous contact. This was noticed by the community
representatives.
94. Panama Conclusion
• A setback driven by political and cultural issues
• Requires attention to culture and efforts to reach out to
leadership and build trust
• Requires explanation of purpose of services (healthy babies
and better functional and cognitive health by prenatal care and
spacing of deliveries rather a focus on family planning)
• Need visible measures and programs to follow the
engagement immediately to show good will
• Need continuous dialogues and communication
• Provide other services besides health, such as education
• Need a qualitative study to assess the barriers and the issues
that contributed to these results in order to address them (this
is crucial). Basically we need a listening tour.
• 94
97. Chiapas Performance Indicator Results
1The baseline value was previously reported at 52.7%. To ensure comparability across rounds and between countries, the baseline estimate was
recalculated to 51.2%.
2The baseline calculation for indicator 4010 only includes doctor and professional nurse as skilled personnel, because professional midwife was not
asked.
3The baseline value was previously reported at 48.5%. To ensure comparability across rounds and between countries, the baseline estimate was
recalculated to 48.9%.
Target Passing
% LB UB % N LB UB % LB UB % LB UB
2020
Women in need of FP who are not
using form of contraception1 HH
51.2% 46.9% 55.6% 53.0% 45.7% 60.1% 36.9% 31.1% 43.2% 44.0% 35.1% 53.2% 45.7% PASS
3035
5 ANC visits with qualified personnel
and according to norms
MRR
6.8% 2.3% 15.3% 12.9% 10.0% 16.3% 0.0% 0.0% 16.1% 7.0% 3.3% 12.9% 16.8% FAIL
4010
Institutional birth with qualified
personnel
2 HH
34.7% 29.5% 40.4% 40.5% 31.4% 50.3% 59.7% 48.7% 69.8% 70.8% 53.6% 83.6% 42.7% PASS
4030
Post partum care within 7 days by
qualified personnel
HH
26.2% 23.0% 29.7% 26.9% 21.1% 33.7% 33.7% 27.0% 41.0% 40.1% 33.8% 46.7% 32.2% PASS
5060 ORS administration for diarrhea HH 48.9% 42.7% 55.2% 57.6% 48.0% 66.7% 53.4% 43.8% 62.7% 62.6% 45.9% 76.7% 63.9% PASS
4050 Immediate postpartum care MRR 0.0% 0.0% 1.8% 47.8% 40.9% 54.9% 0.0% 0.0% 2.5% 10.8% 5.5% 18.5% 30.0% PASS
4090
Active management of 3rd stage of
delivery
MRR
72.3% 65.6% 78.3% 97.3% 94.3% 99.0% 62.4% 53.9% 70.4% 93.2% 86.5% 97.2% 92.3% PASS
4070
Management of neonatal
complications according to norms
MRR
22.8% 16.2% 30.5% 38.5% 31.1% 46.2% 12.5% 0.3% 52.7% 20.7% 11.2% 33.4% 20.0% PASS
4080
Management of obstetric
complications according to norms
MRR
17.9% 11.2% 26.6% 24.4% 19.0% 30.6% 21.1% 9.6% 37.3% 16.8% 10.1% 25.6% 20.0% PASS
5025
MMR vaccine according to card,
children 12-23 months3 HH
48.9% 43.1% 54.6% 49.8% 41.1% 58.5% 48.8% 39.8% 57.9% 41.3% 32.2% 51.0% 55.5% PASS
Baseline (2013) Second Follow-up (2018)
36M
# Indicator short description
Data
source
Intervention Comparison
Baseline (2013) Second Follow-up (2018)
100. 4010: Institutional delivery with skilled
personnel
*Intervention areas only
**The baseline calculation for indicator 4010 only includes doctor and professional
nurse as skilled personnel, because professional midwife was not asked.
100
101. Mexico 3035: 5 ANC visits according to the
norm
MEX I3035 - BL
At least 5 ANC visits
Weight + blood pressure checked at all visits
Fundal height checked (if gestational age >13 weeks at visit)
Fetal movement + fetal heart rate checked (if gestational age >20 weeks at visit)
Blood glucose lab test at least once
HIV lab test at least once
Hemoglobin lab test at least once
Urinalysis lab test test at least once
I3035
MEX I3035 - 18m
At least 5 ANC visits
Weight + blood pressure checked at all visits
Fundal height checked (if gestational age >13 weeks at visit)
Fetal movement + fetal heart rate checked (if gestational age >20 weeks at visit)
Blood glucose lab test at least once
HIV lab test at least once
Hemoglobin lab test at least once
Urinalysis lab test test at least once
I3035
MEX I3035 - 36m
At least 5 ANC visits
Weight + blood pressure checked at all visits
Fundal height checked (if gestational age >13 weeks at visit)
Fetal movement + fetal heart rate checked (if gestational age >20 weeks at visit)
Blood glucose lab test at least once
HIV lab test at least once
Hemoglobin lab test at least once
Urinalysis lab test test at least once
I3035
*HIV test not captured in all records at baseline. Fundal height + fetal checks only captured at first visit if gestational age is eligible.
101
102. Mexico 4050: Postpartum patients
evaluated within 2 hours after delivery
102
*Heart rate was not captured as an alternative at baseline or 1st Follow-up
103. Mexico 4080: Management of
complications
Obstetric complications
N % N %
Women with obstetric
complications managed
according to the norm in the last
two years 106 17.9 (11.2- 26.6) 255 24.3 (19.2- 30.1)
Baseline 2nd Follow-up
CI CI
Neonatal complications
N % N %
Neonates with complications
managed according to the norm
in the last two years 145 22.8 (16.2- 30.5) 190 37.4 (30.5- 44.7)
Baseline 2nd Follow-up
CI CI
103
108. Measles immunization effective coverage
• Despite MMR card coverage
showing only a minimal
increase for intervention areas,
dried blood spot analysis for
measurement of effective
coverage of the MMR vaccine
showed notable progress.
• The antibodies for children has
increased greatly, indicating
that the efforts that SMI
invested in improving the cold
chain have paid off.
• An impressive and a huge
improvement from the
baseline.
Intervention
N % N %
DBS coverage, 12 <= age < 24
(months)
716 61.2% 236 80.5%
DBS coverage among card holders,
12 <= age < 24 (months)
645 63.3% 195 82.2%
Intervention
Baseline Second Follow-up
Comparison
N % N %
DBS coverage, 12 <= age < 24
(months)
302 72.1% 94 69.4%
DBS coverage among card holders,
12 <= age < 24 (months)
276 73.9% 80 65.8%
Comparison
Baseline Second Follow-up
108
109. Measles immunization by card and DBS coverage
• Increase in MMR coverage in SMI intervention areas
• Decrease in MMR coverage in comparison areas
• IDB allowed SMI funds to be used to purchase vaccines and to be used
for all ages, as well as outside of the intervention areas during this time
929 716
329 236
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Card DBS
Intervention
Baseline Second Follow-up
390 302
152 94
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Card DBS
Comparison
Baseline Second Follow-up
N shown inside bar.
109
110. Increase in health service utilization among
Indigenous populations
• Around 75% of the sample population was indigenous at the baseline and
second follow-up in the intervention areas.
• Increases in institutional delivery and PPC observed for the indigenous
population but did not for non-indigenous.
• Performance is much lower in indigenous women but improves significantly
compared to non-indigenous women.
N % SE N % SE N % SE N % SE
Women (age 15-49) delivered in
hospital/health center with skilled
attendant in their most recent
pregnancy in the last two years
1687 26.5 2.5 572 34.5 4.6 373 78.3 2.8 131 78.9 9.8
Women (age 15-49) who received
postpartum care within 7 days with
skilled personnel (doctor, nurse, or
pro. midwife) in their most recent
pregnancy in the last two years
1682 22.7 1.8 573 26.1 3.5 373 45 3 132 32.1 5.2
INTERVENTION - INDIGENOUS INTERVENTION - NONINDIGENOUS
Baseline (2013) Follow-up (2018) Baseline (2013) Follow-up (2018)
110
111. Increase in health service utilization among
Indigenous populations
111
N % SE N % SE N % SE N % SE
Sought care for recent illness 983 54.6 2.7 360 65.5 2.8 262 62.4 3.4 101 67 3.9
Child was hospitalized for recent
illness
237 1.2 0.7 97 5.3 2.1 73 15 6.3 44 4 2.6
Sought care for suspected acute
respiratory infection
1086 50.5 2.6 434 57.9 3.2 291 56.2 4.5 98 52 4.9
Sought care for diarrhea 415 55.3 3.8 166 62.7 3.5 99 49.9 5.7 59 54 5.2
INTERVENTION - INDIGENOUS INTERVENTION - NONINDIGENOUS
Baseline (2013) Follow-up (2018) Baseline (2013) Follow-up (2018)
• The indigenous population increased child care seeking behaviors for all of
these, with the greatest improvement in seeking care for a recent illness
(10.9% increase).
• The nonindigenous population decreased in their care seeking behaviors
except for any recent illness, where there was only a 4.6% increase.
112. Cultural barriers to use of family planning
112
% LB UB % LB UB % LB UB % LB UB
Women in need of FP
who are not using form
of contraception 51.2% 46.9% 55.6% 53.0% 45.7% 60.1% 36.9% 31.1% 43.2% 44.0% 35.1% 53.2%
COMPARISON
Baseline (2013) Second Follow-up (2018) Baseline (2013) Second Follow-up (2018)
INTERVENTION
• Based on our work in the SMI Process Evaluation, we found, especially in
rural areas, that there are many misconceptions about risks and side effects
of contraceptives, as well as religious objections and cultural barriers to
accepting family planning methods.
• Despite these challenges, the unmet need for contraception in intervention
areas only increased by 1.8%, while the comparison area increased by
7.1%. With these major challenges, maintaining contraceptive use is an
achievement rather than allowing the gap to increase greatly for unmet
need.
113. Difference-in-difference analysis in percent of
healthcare out of household expenditure
• Percent of
healthcare out of
household
expenditure
increased by 4.2%
in comparison but
decreased by 4.1%
in intervention areas
• SMI effect is 0.62
Healthcare
expenditure
%
of
household
expenditure
Comparison at follow-up
Comparison at baseline
Intervention at baseline
Intervention at follow-up
Area*Rounds
Least Squares Means Estimate
Effect Label Estimate Standard Error z Value Pr > |z|
Area*Rounds Diff in Diff -0.6246 0.1223 -5.11 <.0001
114. Chiapas Conclusion
• Chiapas met 9/10 of the 36-month performance indicator
targets
• Despite wide confidence intervals, statistically significant
progress observed in key areas
• Strongly believe SMI has influenced hard to reach areas in the
intervention regions and indigenous communities.
• It is clear that the program is working and is having success in
these areas.
• Reaching an effective coverage over 80% in this time frame is
an outstanding achievement.
• Increased MMR coverage is a success
114
116. Conclusions and Future Activities
• Signs of large improvements in countries except for Panama
and Guatemala
• Reasons for failures are outside the Initiative mandate (i.e.
political and economical factors with mistrust of the
Government)
• Findings raise concerns about sustainability on the long run
• On the other hand, impact of the evaluation is apparent in
control areas and even in other parts of the countries
(Nicaragua expansion and Mexico DBS)
• Impact on health facilities is very visible
• Supplies are still a concern (vaccine shortage in Mexico and
lack of proper distributions)
116
117. Conclusions and Future Activities
• Should we continue or not?
• Yes with some changes
• Panama:
o Engage the community with a focus on health education.
o Water quality should be addressed
o Focus on family planning and the role of vaccines (MCH focus)
• Belize, Honduras, El Salvador, and Nicaragua:
o Maintain same level
o Change the targets
o Use one sided test
117
118. Conclusions and Future Activities
• Guatemala and Costa Rica:
o Reduce engagement
o Change targets (higher targets)
o One sided test
o Reduced quantitative evaluation
o More qualitative approach (why, what are the barriers, what
should be prioritized, switch to DBS, and use the failure to
energize the counterparts)
118
119. Conclusions and Future Activities
• Mexico:
o Maintain same level
o Change the targets
o Use one sided test
o Include access to warehouses/storage and distribution of supplies
in the evaluation
o Maintain pressure on effective coverage
o Qualitative evaluation to answer why supplies are a challenge and
what locals could do to improve the situation (role of Chiapas vs.
MOH)
o Cross-country learnings between indigenous experiences with
SMI, for example between Mexico and Panama
119
120. Conclusions and Future Activities
• Should we continue or not?
• Time for a health summit to discuss the road ahead.
o Invite all players (health, education, finance, etc…)
o Share lessons of success and failures
o Discuss challenges and opportunities
o Involve academia
o Use SDGs and HCI as a motivator
o Power of incentives (awards for best performers and most
improved municipalities)
120
123. Costa Rica 10: Methods of pregnancy
prevention
N % N %
Did not use modern contraception 162 26 361 28.4
Used modern contraception 162 74 361 71.6
Condom 123 72.9 270 72.8
Implant* 123 0 270 13.8
Contraceptive pills 123 13.8 270 5.4
IUD* - - 270 4
Injection, patch, or vaginal ring 123 6.7 270 2.3
* At baseline, Implant and IUD were combined. They were separated into two options during the follow-up survey.
Baseline 2013 Second Follow-Up 2018
** Responses for non-modern methods of contraception (e.g. ejaculation outside the vagina) removed from
table
123
124. Guatemala 4050:
Immediate maternal postpartum care
Denominator:
Total number of postpartum care records from basic and complete facilities in the last
two years
Formula:
Patient was checked for blood pressure + temperature + heart rate/pulse four times in
the first hour after delivery, twice in the second hour, and once at discharge
N % CI N % CI N % CI
Postpartum patients who
were evaluated appropriately
during the first two hours
after birth
161 13 (8.3 - 19.2) 266 39.8 (33.9 - 46) 210 37.1 (30.6 - 44.1)
Baseline 1st Follow-up 2nd Follow-Up
124
125. Guatemala 4660: Delivery management
Denominator:
Total number of delivery records in the sample from CAPs and CAIMIs in the last year
Formula:
Patient was attended by doctor / nurse / obstetrician / midwife + administration of oxytocin or other
uterotonic + partograph included in the medical record + cord clamping occurs between 2-3 minutes
after delivery
Note: At baseline and first follow-up, cord clamping time was defined as 90 seconds.
N % CI N % CI N % CI
Delivery managed according to
the norm
68 50 (37.6 - 62.4) 127 50.4 (41.4 - 59.4) 148 96.6 (92.3 - 98.9)
* At baseline and first follow-up, cord clamping time is defined as 90 seconds.
Baseline 1st Follow-up 2nd Follow-Up
125
126. Guatemala 4080: Management of maternal
complications
N % CI N % CI
Obstetric complications managed
according to the norm in the last two
years
138 14.5 (9.1 - 21.5) 179 21.8 (16 - 28.6)
Baseline Second Follow-Up
N % CI N % CI
Sepsis 5 40 (5.3 - 85.3) 5 60 (14.7 - 94.7)
Hemorrhage 69 26.1 (16.3 - 38.1) 100 37 (27.6 - 47.2)
Severe pre-eclampsia 54 0 (0 - 6.6) 64 0 (0 - 5.6)
Eclampsia 10 0 (0 - 30.8) 11 0 (0 - 28.5)
Total 138 14.5 (9.1 - 21.5) 179 21.8 (16 - 28.6)
Baseline Second Follow-Up
126
127. Guatemala 4070: Management of neonatal
complications
N % CI N % CI
Neonatal complications managed
according to the norm in the past two
years
124 13.7 (8.2 - 21.0) 179 9.5 (5.6 - 14.8)
Baseline Second Follow-Up
N % CI N % CI
Sepsis 53 0 (0 - 6.7) 62 3.2 (0.4 - 11.2)
Asphyxia 27 63 (42.4 - 80.6) 16 31.2 (11 - 58.7)
Low birth weight 31 3.2 (0.1 - 16.7) 70 15.7 (8.1 - 26.4)
Prematurity 20 0 (0 - 16.8) 52 5.8 (1.2 - 15.9)
Total 124 13.7 (8.2 - 21.0) 179 9.5 (5.6 - 14.8)
Baseline Second Follow-Up
127
128. Guatemala 4080:
performance by municipality
128
*Value over municipality represents the number of medical records evaluated
129. Guatemala 4070:
performance by municipality
129
*Value over municipality represents the number of medical records evaluated
130. 3040: ANC <= 12 weeks gestation
Gestational age (weeks)
Baseline
18-months
36-months
*Intervention areas only
130
135. 4080: Management of Maternal
Complications
N % N % N % N %
Management of severe pre-eclampsia 25 12 69 17.4 39 12.8 47 0
Management of eclampsia 2 0 6 33.3 5 0 5 0
Management of hemorrhage 54 75.9 114 70.2 45 17.8 19 52.6
Management of sepsis 17 76.5 34 82.4 10 50 8 37.5
Baseline 36-month Baseline 36-month
Basic Complete
*Intervention areas only
135
136. 4103: Neonatal care
NIC Immediate PPC - BL
Apgar score (at 1 or 5 minutes)
Respiratory rate
Weight
Height/length
Head circumference
Evaluation for the presence of malformations
BCG vaccination
Cured the umbilical cord with water & chlorhexidine
Oxytetracycline ophthalmic prophylaxis or chloramphenicol administration
Vitamin K administration
I4103
NIC Immediate PPC - 18m
Apgar score (at 1 or 5 minutes)
Respiratory rate
Weight
Height/length
Head circumference
Evaluation for the presence of malformations
BCG vaccination
Cured the umbilical cord with water & chlorhexidine
Oxytetracycline ophthalmic prophylaxis or chloramphenicol administration
Vitamin K administration
I4103
NIC Immediate PPC- 36m
Apgar score (at 1 or 5 minutes)
Respiratory rate
Weight
Height/length
Head circumference
Evaluation for the presence of malformations
BCG vaccination
Cured the umbilical cord with water & chlorhexidine
Oxytetracycline ophthalmic prophylaxis or chloramphenicol administration
Vitamin K administration
I4103
*Intervention areas only
136
140. Panama 5060: ORS and zinc administration
140
57
1.2 0.6
73.7
6.4 6.2
0
10
20
30
40
50
60
70
80
90
100
Received any ORS Received zinc Received zinc and ORS
%
of
children
Indicator 5060: Oral rehydration solution and zinc
administration
Baseline Second follow-up
141. Panama 4100: Neonatal postpartum care
141
66.5
17.2
11.5 10.8
63.7
21.8
16.7 16.7
0
10
20
30
40
50
60
70
80
90
100
Any check Skilled check within 48 hours,
among only children
Skilled check within 48 hours Skilled in-facility check within
48 hours
%
of
women Indicator 4100: Neonatal postpartum care within 48 hours with
qualified personnel, most recent birth in last two years
Baseline Second follow-up
142. 2020: Unmet need for contraception among
women in need
*Intervention areas only
149. Mexico 3035: 5 ANC visits according to the
norm
Denominator:
Total number of antenatal care records from ambulatory facilities.
Formula:
Ambulatory: Observe the following in the record: woman had at least 5 ANC visits +
physical checkups performed at each visit (weight + blood pressure + uterine height (if
gestational age >13 weeks) + fetal heart rate (if gestational age >20 weeks) + fetal
movement (if gestational age >20 weeks)). Lab tests performed at least once: blood
glucose level + HIV test + Hb level + urinalysis.
N % N % N %
Women of a reproductive age
who received the minimum
required number of ANC care
according to best practices for a
birth in the last two years 73 6.8 (2.3- 15.3) 321 12.5 (9.1- 16.6) 457 12.9 (10.0- 16.3)
2nd Follow-up
CI CI CI
Baseline 1st Follow-up
*At the baseline, fetal heart rate + fetal movements + fundal height were only measured at the first visit if the woman was of the appropriate
gestational age. HIV laboratory test not captured in all facilities at the baseline.
149
151. Mexico 4090: Active management of 3rd
stage of labor
Denominator:
Total number of delivery records at basic and complete facilities in the sample.
Exclude deliveries that did not occur inside the facility.
Formula:
Woman was administered oxytocin/other uterotonic after delivery.
N % N % N %
Oxytocin/other uterotonic was
administered 202 72.3 (65.6- 78.3) 336 83.6 (79.2- 87.4) 254 97.2 (94.4- 98.9)
Baseline 1st Follow-up 2nd Follow-up
CI CI CI
151
152. Mexico 4080: Management of
complications by complication type
Obstetric complications
N % SE N % SE
Hemorrhage 65 23.1 5.2 91 50.5 5.2
Severe pre-eclampsia 37 8.1 4.5 150 8.7 2.3
Eclampsia 3 0 12 16.7 10.8
Sepsis 7 71.4 17.1 6 50 20.4
Total 106 17.9 3.7 255 24.3 2.7
Baseline 2nd Follow-up
Neonatal complications
N % SE N % SE
Low birth weight 31 25.8 7.9 78 47.4 5.7
Prematurity 33 15.2 6.2 41 19.5 6.2
Asphyxia 47 70.2 6.7 41 73.2 6.9
Sepsis 88 13.6 3.7 86 30.2 5
Total 145 22.8 3.5 190 37.4 3.5
Baseline 2nd Follow-up
152